Sex-dependent effects of G protein-coupled estrogen receptor activity on outcome after ischemic stroke

Stroke

Volumn 45, Issue 3, 2014, Pages 835-841

  Broughton, Brad R S ^a   Brait, Vanessa H ^a   Kim, Hyun Ah ^a   Lee, Seyoung ^a   Chu, Hannah X ^a   Gardiner Mann, Chantelle V ^a   Guida, Elizabeth ^a   Evans, Megan A ^a   Miller, Alyson A ^a   Arumugam, Thiruma V ^b   Drummond, Grant R ^a   Sobey, Christopher G ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Apoptosis; Cerebral ischemia; GPER protein; GPR30 protein; Middle cerebral artery stroke

Indexed keywords

CASPASE 3; CASPASE INHIBITOR; DIMETHYL SULFOXIDE; ESTROGEN RECEPTOR; G PROTEIN COUPLED ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG; G PROTEIN COUPLED RECEPTOR 30;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NERVE CELL; NEUROPROTECTION; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; SEX; AGING; ANIMAL; BRAIN; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; MIDDLE CEREBRAL ARTERY STROKE; NEUROLOGIC DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SEXUAL DEVELOPMENT; TREATMENT OUTCOME; WESTERN BLOTTING;

APOPTOSIS; CEREBRAL ISCHEMIA; GPER PROTEIN; GPR30 PROTEIN; MIDDLE CEREBRAL ARTERY STROKE;

AGING; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BRAIN; BRAIN ISCHEMIA; CASPASE INHIBITORS; CEREBRAL INFARCTION; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MICE; NERVOUS SYSTEM DISEASES; OVARIECTOMY; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; REPERFUSION INJURY; SEX CHARACTERISTICS; STROKE; TREATMENT OUTCOME;

EID: 84899141517     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.001499     Document Type: Article

References (35)

1. Dubai DB, Zhu H, Yu J, Rau SW, Shughrue PJ, Merchenthaler I, et al. Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci USA. 2001;98:1952-1957.
2. Morissette M, Le Saux M, D'Astous M, Jourdain S, Al Sweidi S, Morin N, et al. Contribution of estrogen receptors alpha and beta to the effects of estradiol in the brain. J Steroid Biochem Mol Biol. 2008;108:327-338.
3. Brailoiu E, Dun SL, Brailoiu GC, Mizuo K, Sklar LA, Oprea TI, et al. Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system. J Endocrinol. 2007;193:311-321.
4. Broughton BR, Brait VH, Guida E, Lee S, Arumugam TV, Gardiner-Mann CV, et al. Stroke increases g protein-coupled estrogen receptor expression in the brain of male but not female mice. Neurosignals. 2013;21:229-239.
5. Broughton BR, Miller AA, Sobey CG. Endothelium-dependent relaxation by G protein-coupled receptor 30 agonists in rat carotid arteries. Am J Physiol Heart Circ Physiol. 2010;298:H1055-H1061.
6. Filardo E, Quinn J, Pang Y, Graeber C, Shaw S, Dong J, et al. Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology. 2007;148:3236-3245.
7. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science. 2005;307:1625-1630.
8. Zhang B, Subramanian S, Dziennis S, Jia J, Uchida M, Akiyoshi K, et al. Estradiol and G1 reduce infarct size and improve immunosuppression after experimental stroke. J Immunol. 2010;184:4087-4094.
9. Lebesgue D, Traub M, De Butte-Smith M, Chen C, Zukin RS, Kelly MJ, et al. Acute administration of non-classical estrogen receptor agonists attenuates ischemia-induced hippocampal neuron loss in middle- Aged female rats. PLoS One. 2010;5:e8642.
10. Liu F, Lang J, Li J, Benashski SE, Siegel M, Xu Y, et al. Sex differences in the response to poly(ADP-ribose) polymerase-1 deletion and caspase inhibition after stroke. Stroke. 2011;42:1090-1096.
11. Dennis MK, Burai R, Ramesh C, Petrie WK, Alcon SN, Nayak TK, et al. In vivo effects of a GPR30 antagonist. Nat Chem Biol. 2009;5:421-427.
12. Bologa CG, Revankar CM, Young SM, Edwards BS, Arterbum JB, Kiselyov AS, et al. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol. 2006;2:207-212.
13. Brait VH, Jackman KA, Walduck AK, Selemidis S, Diep H, Mast AE, et al. Mechanisms contributing to cerebral infarct size after stroke: gender, reperfusion, T lymphocytes, and Nox2-derived superoxide. J Cereb Blood Flow Metab. 2010;30:1306-1317.
14. Brait VH, Martin KR, Corlett A, Broughton BR, Kim HA, Thundyil J, et al. Over-expression of DSCR1 protects against post-ischemic neuronal injury. PLoS One. 2012;7:e47841.
15. Brait VH, Rivera J, Broughton BR, Lee S, Drummond GR, Sobey CG. Chemokine-related gene expression in the brain following ischemic stroke: No role for CXCR2 in outcome. Brain Res. 2011;1372:169-179.
16. McCarthy CA, Vinh A, Broughton BR, Sobey CG, Callaway JK, Widdop RE. Angiotensin II type 2 receptor stimulation initiated after stroke causes neuroprotection in conscious rats. Hypertension. 2012;60:1531-1537.
17. Arumugam TV, Chan SL, Jo DG, Yilmaz G, Tang SC, Cheng A, et al. Gamma secretase-mediated Notch signaling worsens brain damage and functional outcome in ischemic stroke. Nat Med. 2006;12:621-623.
18. Arumugam TV, Cheng YL, Choi Y, Choi YH, Yang S, Yun YK, et al. Evidence that gamma-secretase-mediated Notch signaling induces neuronal cell death via the nuclear factor-kappaB-Bcl-2-interacting mediator of cell death pathway in ischemic stroke. Mol Pharmacol. 2011;80:23-31.
19. Owman C, Blay P, Nilsson C, Lolait SJ. Cloning of human cDNA encoding a novel heptahelix receptor expressed in Burkitt's lymphoma and widely distributed in brain and peripheral tissues. Biochem Biophys Res Commun. 1996;228:285-292.
20. Gillies GE, McArthur S. Estrogen actions in the brain and the basis for differential action in men and women: A case for sex-specific medicines. Pharmacol Rev. 2010;62:155-198.
21. Lebesgue D, Chevaleyre V, Zukin RS, Etgen AM. Estradiol rescues neurons from global ischemia-induced cell death: Multiple cellular pathways of neuroprotection. Steroids. 2009;74:555-561.
22. Gibson CL, Gray LJ, Murphy SP, Bath PM. Estrogens and experimental ischemic stroke: A systematic review. J Cereb Blood Flow Metab. 2006;26:1103-1113.
23. Rau SW, Dubai DB, Bottner M, Gerhold LM, Wise PM. Estradiol attenuates programmed cell death after stroke-like injury. J Neurosci. 2003;23:11420-11426.
24. Dubai DB, Shughrue PJ, Wilson ME, Merchenthaler I, Wise PM. Estradiol modulates bcl-2 in cerebral ischemia: A potential role for estrogen receptors. J Neurosci. 1999;19:6385-6393.
25. Liu F, Li Z, Li J, Siegel C, Yuan R, McCullough LD. Sex differences in caspase activation after stroke. Stroke. 2009;40:1842-1848.
26. Ding Q, Gros R, Limbird LE, Chorazyczewski J, Feldman RD. Estradiol-mediated ERK phosphorylation and apoptosis in vascular smooth muscle cells requires GPR 30. Am J Physiol Cell Physiol. 2009;297:C1178-C1187.
27. Kimura M, Mizukami Y, Miura T, Fujimoto K, Kobayashi S, Matsuzaki M. Orphan G protein-coupled receptor, GPR41, induces apoptosis via a p53/Bax pathway during ischemic hypoxia and reoxygenation. J Biol Chem. 2001;276:26453-26460.
28. Liu SB, Zhang N, Guo YY, Zhao R, Shi TY, Feng SF, et al. G-protein-coupled receptor 30 mediates rapid neuroprotective effects of estrogen via depression of NR2B-containing NMDA receptors. J Neurosci. 2012;32:4887-4900.
29. Recchia AG, De Francesco EM, Vivacqua A, Sisci D, Panno ML, Ande S, et al. The G protein-coupled receptor 30 is up-regulated by hypoxia-inducible factor-1 alpha (HIF-1 alpha) in breast cancer cells and cardiomyocytes. J Biol Chem. 2011;286:10773-10782.
30. Westberry JM, Prewitt AK, Wilson ME. Epigenetic regulation of the estrogen receptor alpha promoter in the cerebral cortex following ischemia in male and female rats. Neuroscience. 2008;152:982-989.
31. Gros R, Ding Q, Sklar LA, Prossnitz EE, Arterbura JB, Chorazyczewski J, et al. GPR30 expression is required for the mineralocorticoid receptor-independent rapid vascular effects of aldosterone. Hypertension. 2011;57:442-451.
32. Rigsby CS, Cannady WE, Dorrance AM. Aldosterone: good guy or bad guy in cerebrovascular disease? Trends Endocrinol Metab. 2005;16:401-406.
33. Manwani B, McCullough LD. Sexual dimorphism in ischemic stroke: Lessons from the laboratory. Womens Health (Lond Engl). 2011;7:319-339.
34. Siegel C, Tirtzo C, McCullough LD. Sex differences in cerebral ischemia: possible molecular mechanisms. J Neurosci Res. 2010;88:2765-2774.
35. Glader EL, Stegmayr B, Norrving B, Tergnt A, Hulter- Asberg K, Wester PO, et al; Riks-Stroke Collaboration. Sex differences in management and outcome after stroke: A Swedish national perspective. Stroke. 2003;34:1970-1975.